Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab182879-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
| Ab182879-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $349.90 | |
| Ab182879-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $899.90 | |
| Ab182879-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,439.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Nurulimab (anti-CTLA-4) - Primary antibody, specific to CTLA4, Human IgG1 |
|---|---|
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
| Specificity | CTLA4 |
| Conjugation | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Nurulimab (anti-CTLA-4) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab (anti-CTLA-4) can be can be used in research of melanoma. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 25.7 kDa (Light Chain) & 51.1 kDa (Heavy Chain), under reducing conditions; 198.2 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS | 2168561-20-2 |
Nurulimab (anti-CTLA-4) (Ab182879) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling CTLA-4 (red) with Nurulimab (anti-CTLA-4) (Ab182879). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nurulimab (anti-CTLA-4) (Ab182879) - ELISA
Immobilized Recombinant Human CTLA4 protein (rp176276) at 1.0 μg/mL can bind Nurulimab (anti-CTLA-4) (Ab182879) with the EC₅₀ of 22.16 ng/mL.
Nurulimab (anti-CTLA-4) (Ab182879) - SEC
The purity of Nurulimab (anti-CTLA-4) (Ab182879) is more than 95% verified by HPLC.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0505102 | Certificate of Analysis | May 06, 2024 | Ab182879 |
| ZJ24F0505101 | Certificate of Analysis | May 06, 2024 | Ab182879 |
| ZJ24F0505100 | Certificate of Analysis | May 06, 2024 | Ab182879 |
